[
  {
    "ts": null,
    "headline": "Insulet Corp. stock underperforms Tuesday when compared to competitors",
    "summary": "Insulet Corp. stock underperforms Tuesday when compared to competitors",
    "url": "https://finnhub.io/api/news?id=b8bdcaed42d88109ae27b49e1f8effd5988e5a341422610ec25eda1f87db8a23",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749575100,
      "headline": "Insulet Corp. stock underperforms Tuesday when compared to competitors",
      "id": 135253835,
      "image": "",
      "related": "PODD",
      "source": "MarketWatch",
      "summary": "Insulet Corp. stock underperforms Tuesday when compared to competitors",
      "url": "https://finnhub.io/api/news?id=b8bdcaed42d88109ae27b49e1f8effd5988e5a341422610ec25eda1f87db8a23"
    }
  },
  {
    "ts": null,
    "headline": "Insulet Corporation's Omnipod 5 App for Iphone with Dexcom G7 Integration Now Available to All U.S. Users",
    "summary": "Insulet Corporation announced that the Omnipod®? 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System. With this latest integration, the Omnipod 5 Automated...",
    "url": "https://finnhub.io/api/news?id=2dd81a9d5efb23f3ca0934d7330e68a6577e1e9115a0bf7a6203aa0cb373887c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749560784,
      "headline": "Insulet Corporation's Omnipod 5 App for Iphone with Dexcom G7 Integration Now Available to All U.S. Users",
      "id": 135162408,
      "image": "",
      "related": "PODD",
      "source": "Finnhub",
      "summary": "Insulet Corporation announced that the Omnipod®? 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring System. With this latest integration, the Omnipod 5 Automated...",
      "url": "https://finnhub.io/api/news?id=2dd81a9d5efb23f3ca0934d7330e68a6577e1e9115a0bf7a6203aa0cb373887c"
    }
  },
  {
    "ts": null,
    "headline": "Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users",
    "summary": "ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System.",
    "url": "https://finnhub.io/api/news?id=3a2aba343d9e47be66b1e005eff8861f14dd8340435147679031831dec2de14e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749558600,
      "headline": "Insulet’s Omnipod® 5 App for iPhone with Dexcom G7 Integration Now Available to all U.S. Users",
      "id": 135149348,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "ACTON, Mass., June 10, 2025--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless insulin pump technology, is excited to announce that the Omnipod® 5 App for iPhone is now compatible with the Dexcom G7 Continuous Glucose Monitoring (CGM) System.",
      "url": "https://finnhub.io/api/news?id=3a2aba343d9e47be66b1e005eff8861f14dd8340435147679031831dec2de14e"
    }
  },
  {
    "ts": null,
    "headline": "Transcript : Insulet Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09",
    "summary": "Presenter SpeechDavid Roman Well, good morning, everyone. We'll go ahead and get started here, just to make a quick housekeeping announcement that presentations are not open to members of the",
    "url": "https://finnhub.io/api/news?id=a0e32946cd3dbd1ed3251e2f7a1f88af7bc4f6325f638ce4af34ec5cd2fbbb76",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749550818,
      "headline": "Transcript : Insulet Corporation Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 09",
      "id": 135150310,
      "image": "",
      "related": "PODD",
      "source": "Finnhub",
      "summary": "Presenter SpeechDavid Roman Well, good morning, everyone. We'll go ahead and get started here, just to make a quick housekeeping announcement that presentations are not open to members of the",
      "url": "https://finnhub.io/api/news?id=a0e32946cd3dbd1ed3251e2f7a1f88af7bc4f6325f638ce4af34ec5cd2fbbb76"
    }
  },
  {
    "ts": null,
    "headline": "PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption",
    "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 28.8% year on year to $569 million. On top of that, next quarter’s revenue guidance ($608.2 million at the midpoint) was surprisingly good and 5.5% above what analysts were expecting. Its non-GAAP profit of $1.02 per share was 29.7% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=b37cf9c84596621214223d2ee422d1812c9c70c9d99c7e4c85377a620e3ff860",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1749544577,
      "headline": "PODD Q1 Earnings Call: Insulet Highlights New Leadership and Strong Omnipod Adoption",
      "id": 135149349,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "PODD",
      "source": "Yahoo",
      "summary": "Insulin delivery company Insulet Corporation (NASDAQ:PODD) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 28.8% year on year to $569 million. On top of that, next quarter’s revenue guidance ($608.2 million at the midpoint) was surprisingly good and 5.5% above what analysts were expecting. Its non-GAAP profit of $1.02 per share was 29.7% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=b37cf9c84596621214223d2ee422d1812c9c70c9d99c7e4c85377a620e3ff860"
    }
  }
]